Enliven Therapeutics, Inc. (ELVN)

NMS – Real Time Price. Currency in USD

59.32

+0.54 (0.92%)

Market open: Aug 12, 2026, 10:44 AM EDT

57.40

-1.38 (-2.35%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

05.08.2026

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Announced positive Phase 1 clinical data for ELVN-001 in CML, demonstrating encouraging ELVN-001 efficacy data and a favorable safety and tolerability profile Reached alignment with the FDA on key Phase 3 trial design components Strong balance sheet with $895 million in cash, cash equivalents and marketable securities, which is expected to provide cash runway into 2030 BURLINGAME, Calif., Aug. 5, 2026 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today reported financial results for the second quarter ended June 30, 2026, and provided a business update.

Videos

No Data

There is no data to display

Press releases

05.08.2026

Enliven Therapeutics, Inc. (ELVN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Videos

No Data

Press releases

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Videos

No Data

Press releases

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Search stocks

Enliven Therapeutics, Inc. (ELVN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Videos

No Data

Press releases

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update

Videos

No Data

Press releases

Enliven Therapeutics Reports Second Quarter Financial Results and Provides a Business Update